文献速递眼底病与葡萄膜炎

糖尿病视网膜病变患病率与发病率在种族和民族间的差异

RACIAL AND ETHNIC DIFFERENCES IN PREVALENCE AND INCIDENCE OF DIABETIC RETINAL DISEASE.
PubMed 文献 · Retina · 2026-01-01

该回顾性队列研究分析了2000年至2022年美国商业和Medicare Advantage健康计划中糖尿病患者的糖尿病视网膜病变(DRD)及其威胁视力形式的患病率和发病率趋势。结果显示,黑人或非裔美国人(B/AA)患者的DRD患病率每年均高于白人,西班牙裔和亚裔最初低于白人但现已更高,西班牙裔患病率最高。自2009年以来,西班牙裔和B/AA患者的DRD、糖尿病黄斑水肿(DME)和增殖性糖尿病视网膜病变(PDR)发病率高于白人。结论认为B/AA患者的差异持续存在,而西班牙裔患者的差异恶化。

要点

  • 2021年西班牙裔DRD患病率最高(26.0%),其次亚裔(21.2%),白人最低(19.0%)。
  • 自2009年起西班牙裔和B/AA患者的DRD、DME和PDR发病率高于白人(IRR=1.08-1.85)。
  • 2021年西班牙裔PDR患病率(5.0%)高于B/AA(4.3%)和白人(2.9%)。

核心结论

  • B/AA患者糖尿病视网膜病变的患病率和发病率差异持续存在,而西班牙裔患者的差异已恶化。

研究设计与样本

  • 回顾性队列研究,纳入2000年至2022年间商业和Medicare Advantage健康计划的糖尿病患者,按ICD-9/10代码识别白人、黑人或非裔美国人、西班牙裔和亚裔队列。

主要发现

  • B/AA患者每年DRD患病率均高于白人(2021年B/AA:23.1%;W:19.0%;P < 0.001)。
  • 西班牙裔和亚裔患者最初DRD患病率低于白人(2001年H:12.3%;A:11.9%;W:13.1%;P < 0.001),但现已更高,西班牙裔最高(2021年H:26.0%;A:21.2%;W:19.0%;P < 0.001)。
  • DME和PDR患病率在所有组中至2015/2016年增加,后至2021年下降(2021年DME:W:4.5%,B/AA:5.9%,H:5.9%,A:4.7%;2021年PDR:W:2.9%,B/AA:4.3%,H:5.0%,A:2.9%)。
  • 自2009年以来,西班牙裔和B/AA患者的DRD、DME和PDR发病率高于白人(IRR=1.08-1.85;所有比较P < 0.001)。
  • 亚裔患者最初DRD发病率高于白人,但该差异在2021年消失,2022年再次增加(2022年IRR=1.07,95%CI=1.01-1.14)。

临床怎么用

  • 临床中应关注B/AA和西班牙裔糖尿病患者糖尿病视网膜病变的高患病率和发病率差异。
  • 对西班牙裔和B/AA糖尿病患者可能需要更积极的筛查和干预以应对持续存在的差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine prevalence and incidence trends of diabetic retinal disease (DRD) and its vision-threatening forms over the past 20 years among patients with diabetes mellitus (DM) among US racial and ethnic groups. METHODS: A retrospective cohort study of members of commercial and Medicare Advantage health plans between 2000 and 2022 was conducted, with cohorts of White (W), Black/African American (B/AA), Hispanic (H), and Asian (A) patients with DM identified using ICD-9/10 codes. Outcomes included annual prevalence and incidence of DRD, diabetic macular edema (DME), and proliferative diabetic retinopathy (PDR). Multivariable logistic and Poisson regression models analyzed trends in prevalence odds ratios and incidence rate ratios, respectively. RESULTS: B/AA patients had higher prevalence rates of DRD every year analyzed compared with White patients (2021 B/AA:23.1%; W:19.0%; P < 0.001). Both Hispanic (2001 H:12.3%) and Asian (2001:11.9%) patients initially had lower DRD prevalence than White patients (2001:13.1%; P < 0.001 for both); both are now higher with Hispanic patients having the highest rates (2021 H:26.0%; A:21.2%; W:19.0%, P < 0.001). DME and PDR prevalence increased across all groups through 2015/2016, then decreased through 2021 (2021 DME:W:4.5%, B/AA:5.9%; H:5.9%, A:4.7%; 2021 PDR:W:2.9%, B/AA:4.3%, H:5.0%, A:2.9%).Since 2009, incidence rates for DRD, DME, and PDR in Hispanic and B/AA patients have been higher than for White patients (IRR = 1.08-1.85; P < 0.001 for all comparisons). Asian patients initially had higher DRD incidence rates than White patients, but that difference disappeared in 2021 before increasing again in 2022 (2022 IRR = 1.07, 95% CI = 1.01-1.14). CONCLUSION: Disparities in prevalence and incidence of DRD, DME, and PDR persist for B/AA and have worsened for Hispanic patients.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Goblirsch TJ, Yu Y, Cardillo S, et al. RACIAL AND ETHNIC DIFFERENCES IN PREVALENCE AND INCIDENCE OF DIABETIC RETINAL DISEASE. Retina. 2026. PMID: 41914903. doi:10.1097/IAE.0000000000004836

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。